What is Coapt?
Coapt, LLC specializes in cutting-edge myoelectric pattern recognition technology tailored for upper limb prosthetics. Their flagship Complete Control system is designed to provide users with a more natural and intuitive control experience for prosthetic devices. The company's Gen2 system leverages sophisticated machine-learning algorithms to accurately decode muscle signal patterns, enabling a fluid and personalized control interface for individuals with upper limb amputations or congenital limb differences. Coapt's technology boasts broad compatibility with most commercially available myoelectric-controlled prosthesis components, thereby enhancing accessibility for a diverse user base. The overarching mission of Coapt is to drive innovation in prosthetic development, ultimately improving the quality of life for amputees through advanced technological solutions.
How much funding has Coapt raised?
Coapt has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Coapt
PPP
Public-Private Partnership
What's next for Coapt?
The substantial late-stage funding and recent strategic investment signal a pivotal growth phase for Coapt. This capital infusion is expected to accelerate product development, expand market reach, and potentially fund further research into advanced prosthetic control systems. The company's focus on machine learning and intuitive control positions it for continued leadership in the rapidly evolving field of assistive technologies, aiming to further revolutionize the user experience for individuals with limb differences.
See full Coapt company page
